Metraipolis › archive › dc_0bcadb63eb70

Histone-modifying enzymes as drivers and therapeutic targets in androgen-resistant prostate cancer — Europe PMC PMID:41601922

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41601922
DOI
10.3389/fendo.2025.1730397
License (as archived)
solo-consultazione
Archived
2026-11-06T21:19:08.301Z
SHA-256 of the archived text
ecd360a17d388f17e0fa66b0f3408074c5f00f9c49152e3d388e8b34b7be5e3a
Stable URL of this page
https://metraipolis.com/documento/dc_0bcadb63eb70

How to cite

Histone-modifying enzymes as drivers and therapeutic targets in androgen-resistant prostate cancer — Europe PMC PMID:41601922 — Europe PMC (en), https://europepmc.org/article/MED/41601922 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0bcadb63eb70 (Metraipolis archive dc_0bcadb63eb70, sha256 ecd360a17d388f17e0fa66b0f3408074c5f00f9c49152e3d388e8b34b7be5e3a)
BibTeX
@misc{dc0bcadb63eb70,
  title = {Histone-modifying enzymes as drivers and therapeutic targets in androgen-resistant prostate cancer — Europe PMC PMID:41601922},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41601922},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0bcadb63eb70; sha256 ecd360a17d388f17e0fa66b0f3408074c5f00f9c49152e3d388e8b34b7be5e3a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41601922. Agents can read the archived copy with the MCP tool read_document.